{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:53:50Z","timestamp":1790402030921,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1016\/j.jneuroim.2004.02.011","type":"journal-article","created":{"date-parts":[[2004,4,28]],"date-time":"2004-04-28T18:07:34Z","timestamp":1083175654000},"page":"66-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":207,"title":["Intranasal administration of interferon beta bypasses the blood\u2013brain barrier to target the central nervous system and cervical lymph nodes: a non-invasive treatment strategy for multiple sclerosis"],"prefix":"10.1016","volume":"151","author":[{"given":"T.M","family":"Ross","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.M","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.C","family":"Renner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.G","family":"Thorne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.R","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"W.H","family":"Frey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2004.02.011_BIB1","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0304-3940(92)90440-I","article-title":"Nerve growth factor induces proliferation and enhances fiber regeneration in oligodendrocytes isolated from adult pig brain","volume":"135","author":"Althaus","year":"1992","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.jneuroim.2004.02.011_BIB2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/ana.410310317","article-title":"Revised estimate of the prevalence of multiple sclerosis in the United States [comment]","volume":"31","author":"Anderson","year":"1992","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.jneuroim.2004.02.011_BIB4","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/ana.10100","article-title":"Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen's encephalitis","volume":"51","author":"Bien","year":"2002","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.jneuroim.2004.02.011_BIB5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF01315163","article-title":"Tissue distribution of human interferons after exogenous administration in rabbits, monkeys, and mice","volume":"68","author":"Billiau","year":"1981","journal-title":"Archives of Virology"},{"key":"10.1016\/j.jneuroim.2004.02.011_BIB6","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nn0602-849","article-title":"Sniffing neuropeptides: a transnasal approach to the human brain","volume":"5","author":"Born","year":"2002","journal-title":"Nature Neuroscience"},{"key":"10.1016\/j.jneuroim.2004.02.011_BIB7","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1046\/j.1471-4159.1997.69030939.x","article-title":"Interferon-beta is a potent promoter of nerve growth factor production by astrocytes","volume":"69","author":"Boutros","year":"1997","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.jneuroim.2004.02.011_BIB8","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/jnr.10408","article-title":"Nitric oxide synthase is present in the cerebrospinal fluid of patients with active multiple sclerosis and is associated with increases in cerebrospinal fluid protein nitrotyrosine and S-nitrosothiols and with changes in glutathione levels","volume":"70","author":"Calabrese","year":"2002","journal-title":"Journal of Neuroscience Research"},{"key":"10.1016\/j.jneuroim.2004.02.011_BIB9","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0165-5728(98)00139-8","article-title":"Cytokine gene expression in cells derived from CSF of multiple sclerosis patients","volume":"89","author":"Calabresi","year":"1998","journal-title":"Journal of Neuroimmunology"},{"key":"10.1016\/j.jneuroim.2004.02.011_BIB10","doi-asserted-by":"crossref","first-page":"12432","DOI":"10.1073\/pnas.192442999","article-title":"Nerve growth factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice","volume":"99","author":"Capsoni","year":"2002","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.jneuroim.2004.02.011_BIB11","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0165-5728(03)00216-9","article-title":"Interferon-b suppresses herpes simplex virus type 1 replication in trigeminal ganglion cells through an RNase L-dependent pathway","volume":"141","author":"Carr","year":"2003","journal-title":"Journal of Neuroimmunology"},{"key":"10.1016\/j.jneuroim.2004.02.011_BIB12","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/glia.10145","article-title":"Microglia as liaisons between the immune and central nervous systems: functional implications for multiple sclerosis","volume":"40","author":"Carson","year":"2002","journal-title":"Glia"},{"key":"10.1016\/j.jneuroim.2004.02.011_BIB13","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1172\/JCI119571","article-title":"Microglial production of TNF-alpha is induced by activated T lymphocytes. Involvement of VLA-4 and inhibition by interferonbeta-1b","volume":"100","author":"Chabot","year":"1997","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.jneuroim.2004.02.011_BIB14","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1471-4159.1990.tb04155.x","article-title":"Interferon suppresses sympathetic neuronal cell death caused by nerve growth factor deprivation","volume":"55","author":"Chang","year":"1990","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.jneuroim.2004.02.011_BIB15","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1600-0404.1976.tb04333.x","article-title":"Interferon in the serum and cerebrospinal fluid in patients with multiple sclerosis and other neurological disorders","volume":"53","author":"Degre","year":"1976","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1016\/j.jneuroim.2004.02.011_BIB16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0022-510X(96)05320-8","article-title":"Interleukin-12 and tumor necrosis factor-alpha levels in cerebrospinal fluid of multiple sclerosis patients","volume":"147","author":"Drulovic","year":"1997","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1016\/j.jneuroim.2004.02.011_BIB17","first-page":"46","article-title":"Intranasal delivery: bypassing the blood\u2013brain barrier to deliver therapeutic agents to the brain and spinal cord","volume":"2","author":"Frey","year":"2002","journal-title":"Drug Delivery Technology"},{"key":"10.1016\/j.jneuroim.2004.02.011_BIB18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3109\/10717549709051878","article-title":"Delivery of 125I-NGF to the brain vial the olfactory route","volume":"4","author":"Frey","year":"1997","journal-title":"Drug Delivery"},{"key":"10.1016\/j.jneuroim.2004.02.011_BIB19","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.2165\/00003495-200161120-00001","article-title":"Interferon-beta therapy in multiple sclerosis: evidence for a clinically relevant dose response","volume":"61","author":"Goodin","year":"2001","journal-title":"Drugs"},{"key":"10.1016\/j.jneuroim.2004.02.011_BIB20","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0165-5728(97)00172-0","article-title":"Interferon-beta-1-b (IFN-b) decreases induced nitric oxide (NO) production by a human astrocytoma cell line","volume":"82","author":"Guthikonda","year":"1998","journal-title":"Journal of Neuroimmunology"},{"key":"10.1016\/j.jneuroim.2004.02.011_BIB21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0166-2236(96)10071-0","article-title":"Beta-interferon and multiple sclerosis","volume":"20","author":"Hall","year":"1997","journal-title":"Trends in Neurosciences"},{"key":"10.1016\/j.jneuroim.2004.02.011_BIB22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0165-5728(96)00128-2","article-title":"Beta-interferon regulates the immunomodulatory activity of neonatal rodent microglia","volume":"72","author":"Hall","year":"1997","journal-title":"Journal of Neuroimmunology"},{"key":"10.1016\/j.jneuroim.2004.02.011_BIB23","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/ana.410430317","article-title":"Selective inhibition of human glial inducible nitric oxide synthase by interferon-beta: implications for multiple sclerosis","volume":"43","author":"Hua","year":"1998","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.jneuroim.2004.02.011_BIB24","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1212\/WNL.45.7.1277","article-title":"Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. The IFNB Multiple Sclerosis Study Group and The University of British Columbia MS\/MRI Analysis Group [comment]","volume":"45","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2004.02.011_BIB25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0928-0987(00)00087-7","article-title":"Transport of drugs from the nasal cavity to the central nervous system","volume":"11","author":"Illum","year":"2000","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.jneuroim.2004.02.011_BIB26","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1089\/jir.1987.7.429","article-title":"Virus interference: I. The interferon. By A. Isaacs and J. Lindenmann, 1957","volume":"7","author":"Isaacs","year":"1987","journal-title":"Journal of Interferon Research"},{"key":"10.1016\/j.jneuroim.2004.02.011_BIB27","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/archotol.1979.00790160014003","article-title":"Subarachnoid space of the CNS, nasal mucosa, and lymphatic system","volume":"105","author":"Jackson","year":"1979","journal-title":"Archives of Otolaryngology"},{"key":"10.1016\/j.jneuroim.2004.02.011_BIB28","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archneur.1987.00520180013008","article-title":"Intrathecally administered natural human fibroblast interferon reduces exacerbations of multiple sclerosis. Results of a multicenter, double-blind study","volume":"44","author":"Jacobs","year":"1987","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.jneuroim.2004.02.011_BIB29","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/ana.10506","article-title":"Cerebral neurogenesis is induced by intranasal administration of growth factors","volume":"53","author":"Jin","year":"2003","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.jneuroim.2004.02.011_BIB30","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/jnnp.58.1.107","article-title":"Evidence for increased nitric oxide production in multiple sclerosis","volume":"58","author":"Johnson","year":"1995","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1016\/j.jneuroim.2004.02.011_BIB31","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/S0002-9440(10)64677-9","article-title":"Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions","volume":"158","author":"Liu","year":"2001","journal-title":"American Journal of Pathology"},{"key":"10.1016\/j.jneuroim.2004.02.011_BIB32","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0022-510X(01)00532-9","article-title":"Intranasal administration of insulin-like growth factor-I bypasses the blood\u2013brain barrier and protects against focal cerebral ischemic damage","volume":"187","author":"Liu","year":"2001","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1016\/j.jneuroim.2004.02.011_BIB33","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0165-5728(98)00049-6","article-title":"Interferon-beta inhibits mitogen induced astrocyte proliferation in vitro","volume":"86","author":"Malik","year":"1998","journal-title":"Journal of Neuroimmunology"},{"key":"10.1016\/j.jneuroim.2004.02.011_BIB34","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0165-5728(93)90244-S","article-title":"Interferon beta decreases T cell activation and interferon gamma production in multiple sclerosis","volume":"46","author":"Noronha","year":"1993","journal-title":"Journal of Neuroimmunology"},{"key":"10.1016\/j.jneuroim.2004.02.011_BIB35","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJM200009283431307","article-title":"Multiple sclerosis","volume":"343","author":"Noseworthy","year":"2000","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.jneuroim.2004.02.011_BIB36","first-page":"236","article-title":"Multiple sclerosis: pro- and anti-inflammatory cytokines and metalloproteinases are affected differentially by treatment with IFN-beta","volume":"108","author":"Ozenci","year":"2000","journal-title":"Journal of Neuroimmunology"},{"key":"10.1016\/j.jneuroim.2004.02.011_BIB37","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/S0301-472X(99)00109-5","article-title":"Signaling pathways activated by interferons","volume":"27","author":"Platanias","year":"1999","journal-title":"Experimental Hematology"},{"key":"10.1016\/j.jneuroim.2004.02.011_BIB39","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.2042-7158.1991.tb03510.x","article-title":"Transport of cephalexin to the cerebrospinal fluid directly from the nasal cavity","volume":"43","author":"Sakane","year":"1991","journal-title":"Journal of Pharmacy and Pharmacology"},{"key":"10.1016\/j.jneuroim.2004.02.011_BIB40","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/135245859600100504","article-title":"Counteracting effect of IFN-beta on IFN-gamma-induced proliferation of human astrocytes in culture","volume":"1","author":"Satoh","year":"1996","journal-title":"Multiple Sclerosis"},{"key":"10.1016\/j.jneuroim.2004.02.011_BIB41","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2745\/dds.14.365","article-title":"Transnasal delivery of anticancer drugs to the brain tumor: a new strategy for brain tumor chemotherapy","volume":"14","author":"Shingaki","year":"1999","journal-title":"Drug Delivery System"},{"key":"10.1016\/j.jneuroim.2004.02.011_BIB42","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1046\/j.1471-4159.1997.68062547.x","article-title":"Pretreatment of astrocytes with interferon-alpha\/beta impairs interferon-gamma induction of nitric oxide synthase","volume":"68","author":"Stewart","year":"1997","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.jneuroim.2004.02.011_BIB43","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1046\/j.1471-4159.1998.70010432.x","article-title":"Pretreatment of astrocytes with interferon-alpha\/beta prevents neuronal mitochondrial respiratory chain damage","volume":"70","author":"Stewart","year":"1998","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.jneuroim.2004.02.011_BIB44","doi-asserted-by":"crossref","first-page":"907","DOI":"10.2165\/00003088-200140120-00003","article-title":"Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations","volume":"40","author":"Thorne","year":"2001","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/j.jneuroim.2004.02.011_BIB45","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1191\/1352458502ms775oa","article-title":"Incidence of enhancement of the trigeminal nerve on MRI in patients with multiple sclerosis","volume":"8","author":"van der Meijs","year":"2002","journal-title":"Multiple Sclerosis"},{"key":"10.1016\/j.jneuroim.2004.02.011_BIB46","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1084\/jem.191.10.1799","article-title":"Human nerve growth factor protects common marmosets against autoimmune encephalomyelitis by switching the balance of T helper cell type 1 and 2 cytokines within the central nervous system [comment]","volume":"191","author":"Villoslada","year":"2000","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.jneuroim.2004.02.011_BIB47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(03)00341-7","article-title":"Profiles of methotrexate in blood and CSF following intranasal and intravenous administration to rats","volume":"263","author":"Wang","year":"2003","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.jneuroim.2004.02.011_BIB48","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0165-5728(97)00264-6","article-title":"Suppression of acute and protracted-relapsing experimental allergic encephalomyelitis by nasal administration of low-dose IL-10 in rats","volume":"84","author":"Xiao","year":"1998","journal-title":"Journal of Neuroimmunology"},{"key":"10.1016\/j.jneuroim.2004.02.011_BIB51","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1006\/bbrc.1997.6359","article-title":"Isolation and expression of rat interferon beta gene and growth-inhibitory effect of its expression on rat glioma cells","volume":"232","author":"Yokoyama","year":"1997","journal-title":"Biochemical and Biophysical Research Communications"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572804000773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572804000773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T07:59:14Z","timestamp":1759046354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572804000773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":47,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["S0165572804000773"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2004.02.011","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2004,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranasal administration of interferon beta bypasses the blood\u2013brain barrier to target the central nervous system and cervical lymph nodes: a non-invasive treatment strategy for multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2004.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}